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Introduction: la prévalence de l'insuffisance rénale chronique (IRC) augmente et 
malgré les traitements de remplacement rénal telle que la transplantation ou la 
dialyse, la mortalité chez des patients atteints d'une IRC reste très élevée. Les 
maladies cardiovasculaires sont la cause principale de mortalité chez ces patients, et 
le risque de décès dû à une complication cardiovasculaire est chez eux accru de 1 O 
à 20 fois par rapport à la population générale. Même si les facteurs de risque 
cardiovasculaires «traditionnels », principalement l'hypertension artérielle et le 
diabète sont très prévalents chez les patients avec IRC, ils sont insuffisants pour 
expliquer l'excès de mortalité cardiovasculaire. D'autres facteurs de risques « non-
traditionnels » comme l'accumulation du diméthylarginine asymétrique (ADMA), un 
inhibiteur endogène de la synthase d'oxyde d'azote (NO), semblent aussi être 
importants. Chez les patients avec IRC, des taux élevés d'ADMA sont un puissant 
facteur prédictif indépendant de la mortalité cardiovasculaire. Il a également été 
démontré chez des souris que l'ADMA peut être une cause directe de dysfonction 
endothéliale. Cette dernière joue un rôle primordial dans le développement de 
l'athérosclérose, cause principale des complications cardiovasculaires. Le but du 
présent travail est de tester l'hypothèse qu'une réduction du taux d'ADMA après une 
séance unique d'hémodialyse améliore la dysfonction endothéliale. 
Méthodes: la dysfonction endothéliale peut être évaluée dans les microvaisseaux de 
la peau de façon non invasive par fluxmétrie laser Doppler. La vasodilatation cutanée 
induite par un échauffement local de 34 ° à 41°C (hyperémie thermique) est connue 
pour être dépendante de la production endothéliale de NO et a été utilisée dans 
plusieurs études cliniques pour évaluer la dysfonction endothéliale. Nous avons 
recruté 24 patients traités par hémodialyse chronique et également 24 sujets 
contrôles du même âge et sexe. Chez les patients dialysés, l'hyperémie thermique 
est mesuré une fois directement avant une séance d'hémodialyse, et une fois 
directement après une autre séance, toutes deux distantes de 2 à 7 jours. En même 
temps, les taux plasmatiques d'ADMA sont mesurés par la méthode de spectrométrie 
de masse en tandem. Chez les sujets contrôle, l'hyperémie thermique est également 
mesurée à deux reprises, à un intervalle de 2 à 7 jours comme chez les patients 
dialysés et les taux d'ADMA sont déterminés qu'une seule fois. 
Résultats: chez les patients dialysés, les réactions d'hyperémie thermique étaient 
superposables avant et après dialyse, mais moindre que chez les sujets contrôles. 
Par contre, les taux d'ADMA étaient plus élevés avant qu'après dialyse. Les taux 
d'ADMA après dialyse étaient similaires aux taux chez les sujets contrôles. 
Conclusion: cette étude montre que la vasodilatation dépendante de la production 
endothéliale de NO dans la microcirculation cutanée n'est pas influencée par les taux 
plasmatiques d'ADMA chez les patients dialysés. Ces résultats suggèrent que 
d'autres mécanismes sont responsables de la dysfonction endothéliale chez ces 
patients. Ceci met en question le concept que l'accumulation d'ADMA est un facteur 
causal du risque cardiovasculaire élevé et suggère que l'ADMA est juste un 
marqueur du milieu très athérogénique causé par l'IRC. 
Clinical Science (2009) 1 1 7, 00-00 (Printed in Great Britain) doi: 10.1042/CS2008056 I 
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A B S T R A C Tl 
End-stage renal disease patients have endothelial dysfunction and high plasma levels of ADMA 
(asymmetric w-NG,NG-dimethylarginine), an endogenous inhibitor of NOS (NO synthase). The 
actual link between these abnormalities is controversial. Therefore we investigated whether 
HD (haemodialysis) has an acute impact on NO-dependent vasodilation and plasma ADMA in 
these patients. A total of 24 patients undergoing maintenance HD (HD group) and 24 age-
and gender-matched healthy contrais (Control group) were enrolled. The increase in SkBF 
(forearm skin blood flow) caused by local heating to 41 °C (SkBF4 I ), known to depend on 
endothelial NO production, was determined with laser Doppler imaging. SkBF4 I was expressed 
as a percentage of the vasodilatory reserve obtained from the maximal SkBF induced by local 
heating to 43 °C (independent of NO). ln HD patients, SkBF4 I was assessed on two successive 
HD sessions, once immediately before and once immediately after HD. Plasma ADMA was assayed 
simultaneously with MS/MS (tandem MS). ln the Control group, SkBF4 I was determined twice, 
on two different days, and plasma ADMA was assayed once. ln HD patients, SkBF4 I was identical 
before (82.2 ± 13. I %) and after (82.7 ± 12.4 %) HD, but was lower than in contrais (day 1, 
89.6 ± 6.1; day 2, 89.2 ± 6.9 %; P < 0.01 compared with the HD group). ln contrast, plasma ADMA 
was higher before (0.98 ± 0.17 µ,mol/I) than after (0.58 ± 0.10 µ,mol/I; P < 0.01) HD. ADMA levels 
after HD did not differ from those obtained in contrais (0.56 ± 0.1 1 mmol/I). These findings show 
that HD patients have impaired NO-dependent vasodilation in forearm skin, an abnormality not 
acutely reversed by HD and not explained by ADMA accumulation. 
Key words: asymmetric w-NG,NG-dimethylarginine (ADMA), chronic haemodialysis, endothelium-dependent vasodilation, end-
stage renal disease, nitric oxide, skin blood flow. 
Abbreviations: ADMA, asymmetric w-NG,NG-dimethylarginine; BMI, body mass index; BP, blood pressure; CKD, chronic 
kidney disease; CRF, chronic renal failure; d1-ADMA, [2,3,3,4,4,5,S-2H7]-ADMA; DBP, diastolic BP; DDAH, dimethylarginine 
dimethylaminohydrolase; ESRD, end-stage renal disease; FMD, flow-mediated vasodilation; HD, haemodialysis; NOS, NO 
synthase; eNOS, endothelial NOS; PU, perfusion unit; SBP, systolic BP; SkBF, skin blood flow; SkBFmax. maximum SkBF; SPE, 
solid-phase extraction. 
Correspondence: Dr François Feihl (email Francois.Feihl@chuv.ch). 
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INTRODUCTION 
Cardiovascular complications are the most important 
cause of mortality in ESRD (end-stage renal disease) 
patients [1 J. In this population, one contributing factor to 
increased cardiovascular risk might be the accumulation 
of endogenous NOS (NO synthase) inhibitors such as 
ADMA (asymmetric w-NG,NG-dimethylarginine) [2,3]. 
This accumulation appears to be due in large part to a 
down-regulated expression of DDAH ( dimethylarginine 
dimethylaminohydrolase), the enzyme which degrades 
ADMA [4]. In CKD (chronic kidney disease) patients, 
plasma ADMA levels are a strong independent predictor 
of kidney disease progression [5,6] and of all-cause 
cardiovascular mortality [7]. Furthermore, Matsumoto 
et al. [8] have demonstrated in a rat model of CRF 
(chronic renal failure) that ADMA is involved in 
peritubular capillary loss, tubulointerstitial fibrosis and 
proteinuria, thereby contributing to the progression of 
CKD. 
ADMA accumulation can be a direct cause of 
endothelial dysfonction [9], which plays a pivotal role 
in the development of atherosclerosis [10]. Endothelial 
dysfonction, manifested by reduced endothelium-
dependent vasodilation, exists even with a mild chronic 
impairment of renal fonction [11, 12], and in uraemia, as in 
many other pathologies, it has been attributed to reduced 
bioavailability of endothelium-produced NO [13,14]. 
Elevated circulating levels of ADMA have been linked 
to endothelial dysfonction in hypercholesterolaemia [15] 
and in CKD patients [3,4]. The influence of a single HD 
(haemodialysis) session on plasma AD MA levels has been 
described in the literature as highly variable, with a mean 
decrease after HD ranging from 0 to 84 % [16]. The 
impact of an HD-induced acute fall in plasma ADMA on 
endothelial NO-dependent vasodilation is not lmown. 
The aim of the present study was to test in ESRD 
patients the hypothesis that an acute decrease in 
ADMA levels in plasma after a single HD session 
may improve endothelial dysfonction in the cutaneous 
microcirculation. 
Part of this work was presented at the XLV ERA-
EDTA meeting, Stockholm, Sweden, 10-13 May 2008, 
and published in abstract form [16a]. 
MATERIALS AND METHODS 
Subjects 
A total of 24 patients on maintenance HD for more than 
1 mon th were enrolled (HD group; Table 1 ). Patients with 
arteriovenous fistulas on both forearms, dermatological 
pathologies or treatment with organic nitrates were 
excluded. All HD patients were anurie except for six 
of them. The HD technical prescription during the HD 
investigational sessions is described in Table 2 (Table 2). 
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Table 1 Demographic and clinical characteristics of the HD 
patients 
Values are means ± S.D. ACEI, angiotensin-converting enzyme inhibitor; ARB, 
angiotensin Il type 1 receptor. 
Characteristic 
Age (years) 
Gender (male/female) (n) 
BMI (kg/m2) 
Months on HD 
Underlying renal disease (n) 
Diabetic nephropathy 
Hypertensive nephrangiosclerosis 
Chronic glomerulonephritis 
Cyclosporine induced nephropathy 
lgA nephropathy 
Other/unknown 
Co-morbidities (n) 
Diabetes 
Coronary heart disease 
Hypercholesterolaemia 
Polyneuropathy 
Smokers 
Medication ( n) 
ji-Adrenergic blockers 
Calcium-channel blockers 
ACEls 
ARBs 
Antiplatelet therapy 
Diuretics 
Statins 
Recombinant erythropoietin 
HD group (n = 24) 
67.9 ± 13.6 
18/6 
25.6 ± 4.5 
41.6± 68.4 
17 
12 
Il 
Il 
13 
19 
The dialysate temperature was maintained constant at 
37°C. All patients had high-flux filters. 
A total of 24 healthy subjects who were matched to the 
HD group for age and gender were recruited [Contrai 
group; age, 68.8 ± 11.7 years; 17 male and seven female; 
BMI (body mass index), 24.7 ± 2.3 kg/m2]. The contrai 
subjects were ail non-smokers, did not have cardiovascu-
lar or kidney disease, diabetes or dermatological disease, 
and were not taking any medication. 
Ail participants in the present study were Caucasians, 
as skin colour influences laser Doppler flowmetry. 
The studywas approved by the ethics committee of the 
University of Lausanne and conformed to the principles 
outlined in the Declaration of Helsinki. AU participants 
gave written informed consent. 
Assessment of sldn endothelial function 
The measurement of microvascular SkBF (skin blood 
flow) with laser Doppler flowmetry can be used for the 
non-invasive assessment of endothelial fonction in 
the human cutaneous microcirculation [17]. Local heating 
~ Technical HD prescription 
Values are means ± S.D. spKtlVurea. single pool Kt!Vurea• according to the 
second-generation Daudirgas formula [67]. Haemodiafiltration was always online. 
Prescription 
Duration of HD (min) 
Filter type 
HD 
Polysulfone 
Polyamide 
Haemodiafiltration 
Substitution volume (ml/min) 
Blood flow rate (ml/min) 
Dialysate flow rate (ml/min) 
Ultrafiltration volume (kg) 
spKt!V,,., 
214.8± 23.3 
13 out of 2 4 patients 
11 out of 2 4 patients 
19 out of 24 patients 
5 out of 24 patients 
89.0 ± 5.7 
436.3 ± 59.8 
490.4 ± 26.9 
2.5 ± 0.8 
1.4 ±0.2 
of the skin to temperatures below 42 °C typically induces 
a biphasic increase in SkBF with an initial peak and a 
secondary sustained plateau after 20-30 min (thermal 
hyperaemia). This plateau response is lmown to be 
primarily mediated by the local generation of NO [18], 
with recent findings supporting the production by eNOS 
(endothelial NOS), rather than nNOS (neuronal NOS) 
[19]. Thermal hyperaemia has been used in clinical studies 
to investigate endothelium-dependent NO release [20]. 
Its decrease has been shown to be of prognostic value for 
cardiovascular mortality in ESRD patients [21]. 
Measurement of SkBF 
Laser Doppler flowmetry was carried out with a laser 
Doppler imager (LDI; Moor Instruments), as described 
previously [22,23]. This device allows the measurement 
of dermal microvascular blood flow in a region of interest 
with no skin contact. According to the principles of laser 
Doppler flowmetry, SkBF is expressed in PU s (perfusion 
units). 
Local thermal hyperaemia 
The change in SkBF induced by local warming of the skin 
was recorded by means of temperature-controlled water-
filled chambers as described previously [23,24]. Local 
temperature was set at 34 °C until SkBF was stable, then 
was raised to 41 °C in 60 s and maintained at this level for 
28 min. Subsequently, the temperature was increased to 
43°C for another 15 min to induce SkBFmax (maximum 
SkBF) [25]. 
Analytical methods 
Plasma levels of ADMA 
ADMA determination in plasma was performed by elec-
trospray MS/MS (tandem MS). To 60 rd of plasma, 30 µl 
of drADMA ([2,3,3,4,4,5,5-2 H 7]-ADMA) at 1 /l,mol!l 
(Cambridge Isotope Laboratories), 106 µl of water and 
Haemodialysis, ADMA and NO-dependent vasodilation 
4 µlof formic acid were added. The analytes were purified 
by /j,-SPE (micro-solid-phase extraction) using the Oasis 
MCX µElution Plate (Waters). The procedure comprised 
of what is typical for SPE: conditioning of the /l,-SPE 
wells by methanol, application of the diluted samples, 
wash steps with 2 % (v/v) formic acid and methanol, and 
finally elution with 1.25 % (v/v) NH40H in water. 
Chromatographie analysis was performed using a 
Rheos CPS-LC (Flux Instruments) and a PAL SYSTEM 
autosampler (CTC Analysis). Separation of the analytes 
was achieved at 30°C using an At!antis HILIC silica 
2.1 x 50 mm column (Waters). The mobile phases used 
for the chromatographie separation were composed of 
20 mmol/l ammonium formate, 0.4 % (v/v) formic acid 
in water and acetonitrile. The column effluent was mon-
itored using a Triple Quadrupole TSQ Quantum Discov-
ery (Thermo Scientific). The instrument was equipped 
with an electrospray interface and was controlled by the 
Xcalibur software (Thermo Scientific). The samples were 
analysed in the positive-ionization mode operating in a 
cone voltage of 4 k V. The tandem mass spectrometer was 
programmed using the SRM (selected reaction monitor-
ing) mode to allow the [MH+J ions of ADMA at m/z 203 
and that of the internai standard drADMA at m/z 210 
to pass through the first quadrupole (Ql) and into the 
collision cell (Q2). The daughter ions for ADMA and dr 
ADMA are of m/z 46. Calibration curves were computed 
using the ratio of the peak area of the analytes and 
internai standard using a weighted (1/x2) least-squares 
linear regression analysis. 
We did not assay the symmetric form of dimethy-
L-arginine [SDMA (symmetric w-NG,N'G-dimethylar-
ginine)], which is devoid of inhibitory effect on NOS 
activity [3]. 
Plasma levels of L-arginine 
For practical reasons, L-arginine levels in plasma were 
measured using a protocol in our laboratory based on 
HPLC. The analysis was performed using an Agilent 
1100 HPLC system. A reverse-phase was used for 
chromatographie separation [Zorbax Eclipse C 18 column 
AAA ( 4.6 x 150 mm; 3.5 µmol/!); Agilent Technologies]. 
Detection was done by fluorescence measurements at 
340 nm (excitation) and 450 nm (emission). ChemStation 
Rev B 03-01 software (Agilent Technologies) was used 
for data acquisition and analysis. 
An internai standard (50 µl of 1250 1;,mol/l 8-gluco-
saminic acid in 160 g/l 5-sulfosalicylic acid) was added 
to 200 1;,l of plasma. The samples were mixed thoroughly 
and incubated on ice for 1 h. The tubes were centrifuged at 
20 800 g. Then, 30 µl of 200 mmol/l Na2HP04 (pH 7.8) 
was added to 120 µl of supernatant. The samples were 
transferred into HPLC vials for injections. 
Automatic pre-column derivatization with OPA-
3MPA was performed at room temperature (21-24°C) 
© The Authors Journal compilation © 2009 Biochemical Society 
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using an autosampler program in accordance with the 
manufacturer's instructions (Agilent Technologies). 
The mobile phase A was 40 mmol/l NaH2P04 (pH 7.8), 
and mobile phase B was acetonitrile/methanol!water 
(9:9:2, by vol.). The separation was obtained at a flow 
rate of 1 ml/min with a gradient program that allowed 
for 2 min of 0 % B, followed by a 26 min step that raised 
mobile phase B to 20 %. Then, washing at 100 % B for 
10 min and the equilibration steps at 0 % B for 10 min 
were performed for a total run of 48 min. 
Experimental protocol 
HD group 
Each subject was examined on two separate visits 2 or 
3 days apart. Caffeine-containing beverages were avoided 
on the day of the experiments, and smokers were not 
allowed to smoke for at least 8 h before examination. 
The visits were on two successive HD sessions. Thermal 
hyperaemia was recorded, and blood was drawn for 
the determination of plasma ADMA and L-arginine at the 
same visit, once in the hour before and once immediately 
after HD, in a randomized order. The blood sample after 
the HD session was collected after a short equilibration 
period, as usually determined in order to measure 
Kt!Vurea [dialysis quality; where K is dialyser clearance 
for urea, t is time, and Vurea is the urea distribution volume 
(i.e. total body water)] in a standardized fashion. This was 
as follows: dialysate flow stopped, ultrafiltration stopped, 
blood flow reduced to 100 ml/min for 3 min, and blood 
taken from the arterial line. Twelve patients attending the 
morning HD session were thus examined in the morning 
period, and the 12 patients attending the afternoon HD 
session were assessed in the afternoon. Investigations 
were not performed before and after the same HD 
session for the following reasons: (i) we wanted to record 
thermal hyperaemia on exacdy the same skin site on both 
occasions in order to avoid potential confounding by 
spatial variation of the vasodilatory response [22], and 
(ii) we have recendy published results indicating that 
thermal hyperaemia recorded on a particular site can be 
diminished by previous heating of this site carried out a 
few hours before [24]. Measurements were performed in 
the forearm contralateral to the arteriovenous vascular 
access. After an acclimatization period of 10 min, the 
subjects were examined in the supine position with 
the forearm under investigation supported by a vacuum 
splint. The exact location of the site on the examined 
forearm was marked on a transparent acetate film, 
together with the anatomical oudine of the forearm, 
in order to exacdy locate the same site for the SkBF 
measurements performed during the second visit [22]. 
BP (blood pressure) and heart rate were measured 
before and after the recording of thermal hyperaemia 
on the contralateral arm using an automated electronic 
device (Datascope Accutorr 1A; MS Cardio-Medical). 
© The Authors Journal compilation © 2009 Biochemical Society 
Skin temperature was also systematically measured using 
a cutaneous probe (G. Métraux). The investigations 
were carried out in a quiet room with air conditioning. 
Ambient temperature was systematically measured and 
ranged from 23-26 °C. 
Control group 
Each participant in this group also had two separate 
measurement sessions at the same time of day as in the HD 
group (sessions 'before' and 'after'), also on two different 
days. The experimental protocol was identical with that 
followed in the HD group, except for the absence of HD 
and for the fact that plasma ADMA was determined only 
once. 
Data analysis 
Values are presented as means ± S.D., or medians (range) 
in the case of asymmetrical distributions. To take into 
account the biphasic SkBF response to local heating 
[18,23], local thermal hyperaemia was summarized as: 
(i) baseline (average SkBF of the first two measurements); 
(ii) initial peak (maximal SkBF in the first 6 min after the 
beginning of heating); (iii) nadir (minimal SkBF after 
the initial peak); (iv) plateau (average SkBF of the last 
5 min at 41 °C); and (v) SkBFmax (average SkBF of the 
last 5 min at 43 °C). SkBFmax is expressed in PUs, whereas 
all of the other SkBF measurements are expressed as a 
percentage of SkBFmax for normalization purposes [17]. 
Contrary to plateau SkBF, SkBFmax is independent of 
endothelial NO, as are the initial peak and the nadir 
[18,19]. 
Statistical analysis of the SkBF data was carried out 
with univariate repeated-measures ANOVA. When the F 
value was significant, pairwise comparisons were carried 
out with modified Student's t tests (i.e. Fisher-protected 
least-significant difference). The a level of all tests was 
set at 0.05. Ail computations were performed with JMP 
software version 5.0.2 (SAS Institute). 
RESULTS 
Vital parameters and skin temperature values are sum-
marized in Table 3. SBP and DBP (systolic and diastolic 
BPs respectively) were significandy higher in HD patients 
than in contrai subjects (P < 0.01). Compared with 
the Contrai group, mean BP in the HD group was 
significandy higher before (P < 0.01), but similar after, 
the HD session. HD did not affect heart rate, which 
was significandy higher in HD patients than in contrais 
(P < 0.01). Skin temperature at the forearm level was 
slighdy lower in HD patients than in contrais (P < 0.05) 
and was not influenced by HD. This difference may be 
explained, at least in part, by a somewhat lower ambient 
temperature in the examination room used with the HD 
patients, which for practical reasons was located within 
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Table 3 Vital parameters and response of SkBF to local heating (41 °C) 
Values are means ± S.D. ** P < 0.01 compared with alter HD. 0 P < 0.05 and 00 P < 0.01 compared with the Contrai graup. 
Parameter 
Vital parameter 
SBP (mmHg) 
DBP (mmHg) 
Mean BP (mmHg) 
Heart rate (beats/min) 
Weight (kg) 
Skin temperature ( 0 C) 
Ambient temperature ( 0 C) 
SkBP response 
Baseline (% of SkBF max) 
Initial peak (% of SkBF max) 
Nadir (% of SkBF max) 
Plateau (% of SkBF max) 
SkBF max (PUs) 
'O 
0 
.2 
.a 
c: 
~ 
l.L 
~ 100 
fi) 
e ao 
:J 1 60 
0 40 
~ 
.5 20 
HD group 
Before HD Alter HD 
146 ± 23** 00 125 ± 20 
76 ± 11**00 66 ± 14° 
99 ± 13**00 86± 13 
75 ± 13° 0 74 ± 12°° 
75.8 ± 17** 00 73.6± 16.4 
32.5 ± 0.8° 32.6 ± 1.0° 
24.2 ± 0.4° 24.6 ± 0.6° 
16.1 ±4.9 16.7 ± 6.1 
73.4 ± 13.3 72.4 ± 20.4 
51.5 ± 15.5 50.5± 17.9 
82.2 ± 13. I OO 82.7 ± 12.4° 0 
491±163°0 475 ± 174° 0 
B 
Contrai graup 
'Before' 
124 ± 20 
70 ± 14 
88± 13 
63 ±8 
73.2 ± 10.8 
33.2±1.1 
24.8 ± 0.7 
14.4 ± 5.5 
74.2 ± 8.6 
59.0 ± 9.9 
89.6± 6.1 
632 ± 92 
HD·group 
-o- boforo HD 
-•-alter HD 
Control- group 
-o- 'before' 
-<>-'alter' 
'Alter' 
125 ± 18 
71 ±Il 
89± 14 
61±7 
73.2 ± 10.8 
33.3 ± 1.1 
25.0 ± 0.8 
14.7±6.0 
78.6 ± 10.6 
59.0 ± 14.2 
89.2 ± 6.9 
635± 129 
0 ,,--r- rr-•-r-r-rf"r ... ·-r..-t~-.- -rrr-r-rrr-r-..---.--r-r,.--;-- ..- --.---.-.---.--.--..--,.....-.-...--.---, min ule s 
.5 0 5 10 t 5 20 25 30 35 40 45 
Figure 1 Response of SkBF to local heating in patients on chronic HD for ESRD and in control subjects 
(A) SkBF is expressed in PUs; (B) SkBF is expressed as a percentage of the maximum SkBF at 43 °C. Patients on HD and contrai subjects were matched for age and 
gender. Before HD, the hour that preceded one HD session; alter HD, the hour that followed another HD session; 'before' and 'alter', two measurements made 2 or 3 days 
apart in the same contrai subject at the same time of day as in the patients. The two HD sessions (or in contrais the two measurement sessions) were 2 or 
3 days apart. Values are means ± S.D. of 24 subjects per graup. 
the HD ward, whereas the control subjects were studied 
in the physiology laboratory. 
As shown in Figure 1 and Table 3, SkBFmax [i.e. elicited 
by heating at 43 °C (NO-independent) and expressed in 
PUs] was significantly lower in the HD group than in the 
Control group, and completely unaffected by HD. When 
expressed as a percentage of SkBFmm the plateau SkBF 
[i.e. after 30 min of heating at 41 °C (NO-dependent)] 
was significantly lower in HD patients than in controls, 
whereas the initial peak and the nadir responses (both 
independent of endothelial NO production [18,19]) did 
not differ between the groups. None of the variables 
derived from thermal hyperaemia was affected by HD. 
In the Control group, the first and second thermal 
hyperaemia were identical in every respect. 
Measurements in the morning did not differ from those 
in the afternoon in both HD patients and the Control 
group (resu!ts not shown). There was no correlation 
between the temperature of unheated skin (measured in 
the vicinity of the thermally probed area) and any of the 
parameters derived from thermal hyperaemia. This lack of 
correlation makes it very unlikely that the slightly lower 
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Figure 2 Effects of HD on plasma levels of ADMA and 
L·arginine 
ln patients on HD, plasma ADMA and L-arginine levels were assessed in the 
hour that preceded one HD session (before HD) and immediately after another 
HD session (after HD). Plasma ADMA was obtained only once in the Control 
group. (A) Boxes indicate the 25th, 50th and 75th percentile, 1and whiskers 
indicate the range. (B) lndividual changes before and after HD. **P < 0.01 and 
*** P < 0.001 compared with the Control group; 000 P<0.001 compared with 
'before HD'. 
unheated skin temperature of the patients could account 
for the differences between the groups shown in Figure 1 
and Table 3. 
Blood was drawn for the determination of plasma 
ADMA and L-arginine levels simultaneously with SkBF 
measurements on both sessions in the HD group, and 
on only one session in the Control group (Figure 2). 
In the HD group, ADMA and L-arginine levels were 
higher before HD (0.98 ± 0.17 and 70 ± 24 J.lmol!l 
respectively) than after HD (0.58 ± 0.10 and 49 ± 
19 /.lmol/l respectively; P < 0.001 for ADMA and 
P = 0.005 for L-arginine). Before HD, ADMA levels were 
also significantly higher and L-arginine levels significantly 
lower than in the Control group (0.56 ± 0.11 and 88 ± 
23 /.lmol/l; P < 0.001 for both analytes). After HD, 
ADMA levels of the patients did not differ from the values 
of control subjects, whereas L-arginine was considerably 
lower ( 49 ± 19 /.lmol/l; P < 0.001 ). The median relative 
decreases in plasma ADMA and L-arginine levels induced 
by HD were - 40 and - 2 9 % respectively, of the pre-
dialysis value, with a substantial variability between 
patients (range for ADMA, -20 to - 52 %; range for 
L-arginine, - 66 to + 117 % ) (Figure 2B ). 
The plasma concentration L-arginine/ ADMA ratio has 
been advocated as surrogate for NO production capacity 
[15]. In patients, this ratio was considerably lower than in 
© The Authors journal compilation © 2009 Biochemical Society 
+20 
u. 
~ G:' +10 
(/) ai 
::i~ 
Sl ~ 0 
.... "' 
..!!! .5 
• 
a.~ 
. 5 E -10 
111-Cil 0 
c :,!! ! .!!._, -20 
(.) 
-30 
• .. 
• 
• 
• .
• 
r=o.os 
p=0.33 
·0.6 ·0.4 ·0.2 0 
Change in plasma ADMA (µM) 
Figure 3 Correlation between changes in plasma levels of 
ADMA induced by HD and the corresponding changes in the 
plateau Sl<BF response to local heating (41 °C) 
Changes in SkBF are expressed as a percentage of SkBF max elicited by subsequent 
heating to 43 °C (see Figure 1 ). 
control subjects [before HD, 66 (38-136) compared with 
150 (1120-242) in the Control group; P < 0.001 J and there 
was a small, but non-significant, increase in this ratio after 
HD [80 (38-222); P = 0.06] (Figure 2). 
There was no correlation between the changes 
observed between the two HD sessions in the NO-
dependent SkBF plateau and the corresponding changes 
in plasma ADMA (r2 = 0.05, P = 0.33; Figure 3), plasma 
L-arginine (r2 = 0.00, P = 0.95) and L-arginine/ ADMA 
ratio (r2 = 0.02, P = 0.56 ). 
DISCUSSION 
In the present study, we have found that HD markedly 
and transiently decreased the plasma levels of both 
L-arginine and ADMA, with only a small non-significant 
increase in the L-arginine/ ADMA ratio. Concomitantly, 
therewas no acute influence of HD on an NO-dependent 
vasodilatory response in the skin microcirculation. These 
results raise the possibility that, in ESRD patients, 
removal of endogenous NOS inhibitors by HD is 
not efficient in improving endothelial fonction due to 
the concomitant changes induced in the availability of 
L-arginine. Alternatively, mechanisms other than or in 
addition to inhibition of eNOS by accumulated ADMA 
may be responsible for endothelial dysfonction in ESRD. 
Plasma L-arginine and ADMA levels 
Pre-dialysis values 
In the HD group before dialysis, plasma L-arginine was 
30 % lower and plasma ADMA was 40 % higher in 
comparison with values from the Control group, which 
was matched for age and gender. Although not reported 
constantly [26-28], an abnormally low level of circulating 
L-arginine has been a frequent finding in previous studies 
of ESRD patients [29-33], possibly related to deficient 
nutritional status [31], diminished L-arginine synthesis by 
the kidney, chronic loss of this amino acid in the dialysate 
[34], or stimulated transport into cells via the y+ cationic 
amino-acid transporter [33]. 
Retention of ADMA has been uniformly found in 
ESRD patients, although the relative increase in the 
plasma level of this arginine analogue has varied between 
studies from 1.3 to 10 times the normal value (reviewed in 
[16]). Our pre-dialysis and control ADMA results are 
in agreement with those obtained either with HPLC by 
Fleck et al. [29], Wahbi et al. [35] and Schiel et al. [36] 
or with LC-MS (as in the present study) by Martens-
Lobenhoffer et al. [37]. 
Acute impact of HD 
In ESRD patients, the short-term effect of a single 
HD session on the plasma levels of L-arginine has 
been extremely variable between studies, with some 
finding no change [27,28,32,38] while others reported 
decreases ranging from 10-70 % of pre-dialysis values 
[26,39-41]. The present study clearly belongs to the 
second category (Figure 2), although the results differed 
considerably between patients, possibly because of a 
variable redistribution of L-arginine between intracellular 
and extracellular pools (keeping in mind that the former 
is by far the larger) [ 4 2]. 
A recent systematic review identified 19 clinicat studies 
where the acute impact of HD on ADMA plasma levels 
was documented in ESRD patients [16]. Findings were 
highly variable between studies, with a mean percentage 
reduction ranging from 0-84 % . [16]. In the present study, 
HD appeared efficient at decreasing ADMA plasma 
levels (a mean decrease of 40 % ), although there was 
substantial variability between patients in that respect. 
Low ADMA clearance during HD compared with 
other substances of similar chemical structure might 
be explained by significant protein binding [43]. The 
influence of oxidative stress, pro-inflammatory cytokines 
and pH changes on catabolism of ADMA as well as on 
its uptake and release by erythrocytes [44] or other cells 
[ 45] may also be involved. 
Thermal hyperaemia as a non-invasive 
means to evaluate NO-dependent 
vasodilation in CKD 
Two clinicat studies have found that microvascular 
endothelial fonction, as assessed with local thermal 
hyperaemia, was depressed in ESRD patients [21,46], 
and the present study confirms these results (Table 3). 
Furthermore, a prospective study of CRF patients 
showed that impaired skin thermal hyperaemia was 
predictive of cardiovascular mortality after 2 years, 
independently of other conventional risk factors [21]. 
Collectively, these findings support the validity of a 
Haemodialysis, ADMA and NO-dependent vasodilation 
diminished plateau of thermal hyperaemia as an indicator 
of endothelial dysfonction in the setting of CKD. 
In our present study, the interpretation of differences 
in plateau SkBF at 41 °C between patients and contrais 
is complicated by the unequal vasodilatory reserve of the 
skin microcirculation in the two groups, as shown by 
the markedly different SkBFmax (Figure 1 and Table 3). 
In contrast with the submaximal SkBF plateau, SkBFmax 
is insensitive to NOS inhibitors [18] and is thought 
to depend directly on the local density of microvessels 
(i.e. the vasodilatory reserve) [47]. In view of the 
well-established association between hypertension and 
rarefaction of skin capillaries [48] and considering the 
markedly higher BP in the HD group compared with 
the Contrai group (Table 3), it appears likely that the 
lower SkBFmax measured in patients on HD was due, 
at least in part, to the hypertension-related reduction 
in skin capillary density. Another possible explanation 
relates to the well-known angiogenic effect of NO [49]. 
In the mouse, chronic administration of a NOS inhibitor 
induced capillary rarefaction, at least in the kidney 
medulla [50]. Thus microvascular rarefaction in the HD 
group might also have been promoted by chronic NO 
deficiency, which is characteristic of CKD and can be 
due, in part, to ADMA accumulation [34]. 
In view of these considerations, information on 
fonctional (as opposed to structural) mechanisms which 
potentially participate in the observed difference in 
thermal hyperaemia between the two study groups 
can only be extracted by comparing the vasodilatory 
responses nonnalized to SkBFmaxi as we have done in 
the present study. The normalized NO-dependent [18] 
plateau SkBF at 41 °C--was lower in the HD group, 
but the normalized NO-independent [18] early peak 
was not (Table 3). These observations support a specific 
impairment of NO-mediated vasodilation in the skin 
microcirculation of renal failure patients. 
Impact of HD on thermal hyperaemia 
The HD prescription included the withdrawal of 
an amount of fluid sufficient to cause significant 
hypovolaemia (i.e. a mean ultrafiltration volume of 
2.5 litres; Table 2), thus explaining the fall in BP that 
occurred in the course of the session (Table 3). This in 
turn may have triggered a baroreflex that could have had 
an impact upon skin vasoreactivity. 
Interestingly, despite an important BP decrease during 
HD, basal SkBF as well as SkBFmax were not affected 
(Table 3). This suggests stable haemodynamic conditions 
in the cutaneous microcirculation even with important 
systemic haemodynamic modifications, making this 
method an interesting tool for the assessment of 
microvascular fonction in various conditions. 
The actual impact of HD on endothelial fonction 
remains controversial. We did not find any difference in 
the thermal hyperaemic response before and after HD. 
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Therefore, at least in the dermal microcirculation, HD 
does not appear to negatively or positively influence 
NO-dependent vasodilation in the short term, although 
its long-term impact in that respect cannot be inferred 
from our present findings. Our present results are 
consistent with some, but not ail, previous findings 
made in patients on maintenance HD. The HD session 
had no effect on FMD (flow-mediated vasodilation) of 
the brachial artery [51], endothelium-dependent vascular 
reactivity assessed by applanation tonometry [28] or the 
response of the skin microcirculation to iontophoretic 
application of acetylcholine [52], an endothelium-
dependent vasodilator. However, some investigators have 
found that endothelium-dependent vasodilation was 
acutely reduced after HD, possibly because of the 
induced oxidative stress [53,54], the amount of which 
appears to depend on the type of dialysis filter used 
[55]. Improvement in endothelial fonction immediately 
after the HD session has also been reported [26,56,57]; 
however, we emphasize that, with one exception [52], ail 
of these studies did not specifically assess endothelium-
dependent vasodilation in the microcirculation. 
ADMA and NO-dependent vasodilation 
in CKD 
In the present study, we observed no correlation between 
plasma ADMA levels and endothelial NO-dependent 
vasodilation in the cutaneous microcirculation (Figure 3 ). 
More importantly, HD acutely reduced the plasma 
concentration of ADMA (Figure 2), but did not have 
any impact on NO-dependent vasodilation (Figure 1). 
Our results are consistent with the findings of Chan 
et al. [58], who observed a complete dissociation between 
the changes in FMD and the changes in plasma ADMA 
levels which followed an increase in the dose of dialysis 
(i.e. a switch from conventional to nocturnal HD). 
Another study in patients on peritoneal dialysis reported 
that ADMA levels were related to basal, but not to 
acetylcholine-stimulated, NO bioactivity in the forearm 
circulation [59]. Cross et al. [56] did not find any 
correlation before and after an HD session between 
plasma ADMA or homocysteine concentrations and 
FMD and they concluded that the impaired conduit 
artery endothelial fonction in ESRD was due to the 
total burden of circulation inhibitors rather any single 
molecular species. On the other hand, Yilmaz et al. [60] 
found a significant negative correlation between FMD 
and ADMA levels before and 4 weeks after kidney trans-
plantation, suggesting that increased ADMA levels might 
be one of the contributors to endothelial dysfonction in 
ESRD patients. However, their study population was 
much younger (mean age, 27.9±9.l years) than those 
in the studies by Chan et al. [5 8] ( 41 ± 2 years ), Cross 
et al. [56] (43 ± 3.5 years) and ours (the present study; 
68±14 years), and the dialysis time of these patients 
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before transplantation was not reported. In CRF, it is 
conceivable that the contribution of ADMA accumula-
tion to impaired NO-dependent vasodilation varies with 
patient age and/or disease duration in this setting. 
The dissociation between changes in ADMA levels 
and changes in NO-dependent vasodilation observed 
in two studies as well as in our present study could 
be due to a concomitant reduction in NOS substrate 
availability, as possibly reflected by the acute decrease 
in plasma levels of L-arginine caused by HD (Figure 2). 
However, this is not supported by the findings of Cross 
et al. [56], who examined ESRD patients immediately 
before an HD session and were unable in these conditions 
to augment the NO-dependent vasodilation of the 
brachial artery (FMD) or of the forearm microvasculature 
(intra-arterial infusion of acetylcholine) by the systemic 
or intra-arterial infusion of L-arginine [61]. Another 
explanation might reside in the capacity of endothelial 
cells to concentrate ADMA. Cellular studies on bovine 
aortic endothelial cells have shown that intracellular 
ADMA levels could be 5-10 times higher than outside 
the cell [45]. There is a continuous low-level production 
of ADMA from the proteolysis of methylated arginine 
residues on various proteins [3], but its concentration 
is kept below a threshold concentration for inhibition 
of NOS by the activity of DDAH, the enzyme 
which degrades ADMA [4]. However under specific 
conditions, such as the addition of ADMA to the 
medium of cultured endothelial cells [45], administration 
of exogenous ADMA to experimental animais or hup1ans 
[62] and DDAH deficiency in mice [9], intracellular 
ADMA may reach levels sufficient to inhibit NOS 
fonction and endothelium-dependent vasodilation. To 
date, it is not known how the intracellular environment 
tracks the extracellular concentration of ADMA when 
the latter varies rapidly. Nor is it clear whether high 
extracellular ADMA has biological effects in its own 
right or is merely a marker of high intracellular levels 
[3]. Alternatively, our results could mean that inhibition 
of NOS by accumulated ADMA is not the main culprit 
for reduced NO bioactivity in ESRD patients. Other 
potential mechanisms include scavenging of NO by 
ROS (reactive oxygen species), reduced expression of 
eNOS [4], possibly mediated by the accumulation of 
advanced glycation end-products [63], deficient supply 
of L-arginine or inhibition of L-arginine transport into 
cells [34]. 
Study limitations 
One limitation of the present study is that the potential 
vascular impact of HD was not tested in isovolaemic 
conditions, as shown by the substantial ultrafiltration 
volume withdrawn from patients (Table 2). The 
resulting decrease in BP (Table 3) may have triggered 
a baroreflex-mediated sympatho-adrenergic activation, 
with the resulting vasoconstriction then masking any 
positive influence of reduced ADMA levels on thermal 
hyperaemia. Although not supported by the absence 
of any effect of HD on basal SkBF (Table 3), this 
interpretation of our findings cannot be ruled out. In 
practical terms, however, our results would still imply a 
limited or non-existent overall impact of acutely reduced 
ADMA levels on NO-dependent skin vasodilation, since 
HD is not usually carried out in isovolaemic conditions. 
Temperature of the dialysa te was kept at 37°C. ln such 
conditions, it is possible that HD caused an increase 
in core temperature [64], thus adding a complicating 
influence on the regulation of SkBF [65]. However, if 
there were core temperature changes in our present study, 
they appear to have had a minimal influence on the 
cutaneous microcirculation, since skin temperature as 
well as basal SkBF were unaffected by HD (Table 3). 
Another possible limitation is the fact that microvas-
cular reactivity as well as blood parameters were not 
determined before and after the same HD session, for the 
specific reasons indicated in the Materials and methods 
section. However, this feature of our study design has 
limited potential for confounding, because, in every 
patient, HD prescription was identical between the two 
successive HD sessions. ln stable ESRD patients (as were 
those of the present study), haemodynamic conditions 
either before or after HD are reproducible between HD 
sessions [66]. 
Finally, for the reasons explained in the Materials and 
methods section, plasma levels of ADMA and L-arginine 
were assayed with different methods. As long as each 
analyte was consistently assayed with the same technique, 
however, the validity of comparisons made between the 
groups as well as within the HD group (Figure 3) should 
not be affected. 
Conclusions 
ln summary, the present study shows for the first time that 
endothelial NO-dependent vasodilation in the cutaneous 
microcirculation is not influenced by the plasma 
level of ADMA in patients on maintenance HD. 
These results suggest that mechanisms other than or 
in addition to inhibition of eNOS by accumulated 
ADMA are responsible for endothelial dysfonction in 
these patients. They call into question the concept 
that the accumulation of ADMA is a causal factor for 
the increased cardiovascular risk in ESRD patients and 
suggest that ADMA is more likely to represent just a 
marker of the highly atherogenic environment caused by 
CKD. 
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